OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
27
Results
Show all
Save search
Copy query
Show results for
Unknown
(26)
Multiomics
(1)
Proteomics
(1)
Repository
MassIVE
(1)
Instrument Platform
LTQ Orbitrap Velos
(1)
Q Exactive
(1)
Publication Date
2017
(1)
Release Date
2017
(4)
2022
(3)
2019
(3)
2016
(3)
2024
(2)
2015
(2)
2014
(2)
2009
(2)
2025
(1)
2023
(1)
2021
(1)
2020
(1)
2010
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Alveolar Injury and Regeneration Following Deletion of ABCA3
Lipidomics and proteomics characterization of lipid and protein changes in BALF from ABCA3 knockout mice compared to control.
ORGANISM(S):
Mus Musculus (ncbitaxon:10090)
2017-08-22
|
MSV000081473
|
MassIVE
Cite
Koolpinyah and Yata viruses: two newly recognised ephemeroviruses from tropical regions of Australia and Africa.
Not available
S-EPMC4274224
|
biostudies-literature
Cite
Arboretum and Puerto Almendras viruses: two novel rhabdoviruses isolated from mosquitoes in Peru.
Not available
S-EPMC3973475
|
biostudies-literature
Cite
Antibiotic resistance prediction for
Mycobacterium tuberculosis
from genome sequence data with Mykrobe.
Not available
S-EPMC7004237
|
biostudies-literature
Cite
Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing.
Not available
S-EPMC7690900
|
biostudies-literature
Cite
Affinity maturation endows potent activity onto class 6 SARS-CoV-2 broadly neutralizing antibodies.
Not available
S-EPMC11725916
|
biostudies-literature
Cite
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern.
Not available
S-EPMC9482529
|
biostudies-literature
Cite
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia.
Not available
S-EPMC9159941
|
biostudies-literature
Cite
Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level.
Not available
S-EPMC10060887
|
biostudies-literature
Cite
Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study.
Not available
S-EPMC6398689
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
